Literature DB >> 8961672

Clinical spectrum of Pseudomonas putida infection.

C H Yang1, T Young, M Y Peng, M C Weng.   

Abstract

The clinical and microbiologic characteristics of 55 cases of Pseudomonas putida infection in 53 patients in a medical center in Taiwan from April 1988 to March 1993 are reported. P. putida was cultured in the decreasing order of frequency from urine (24 isolates), sputum (12), blood (10), wound discharge (3), peritoneal fluid (3), cerebrospinal fluid (2) and umbilical swab (1). Of the adult patients, 23% (12/53) were considered to be contaminated or colonized with P. putida. Of the 41 patients with manifest disease. 17 (41%) had urinary tract infections, 10 (24%) had pneumonia, 8 (19%) had septicemia, 3 (7%) had wound infections, 2 (5%) had meningitis and 1 (2%) had peritonitis. Of these, 55% were nosocomial infections. The case fatality rate was 29% (12/41). There was no significant correlation between patient mortality and the type of disease caused by the bacterium. Results of in vitro susceptibility tests suggested that imipenem and ceftazidime were more effective than other antimicrobials. This study indicates that the clinical spectrum of diseases caused by P. putida is broader and the incidence of true infection is higher than previously expected, especially among hospitalized patients who undergo invasive procedures such as placement of intravascular devices, urinary catheterization and intubation.

Entities:  

Mesh:

Year:  1996        PMID: 8961672

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  17 in total

1.  Pseudomonous putida meningitis in a healthy adult.

Authors:  Shuta Toru; Tetsuro Maruyama; Takumi Hori; Naoki Gocho; Takayoshi Kobayashi
Journal:  J Neurol       Date:  2008-08-01       Impact factor: 4.849

2.  Class II transposon-borne structure harboring metallo-beta-lactamase gene blaVIM-2 in Pseudomonas putida.

Authors:  Laurent Poirel; Ludovic Cabanne; Louis Collet; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

3.  Pseudomonas putida septicemia in a special care nursery due to contaminated flush solutions prepared in a hospital pharmacy.

Authors:  Joseph F Perz; Allen S Craig; Charles W Stratton; Stanley J Bodner; Walter E Phillips; William Schaffner
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

4.  Nosocomial Pseudomonas putida Meningitis: A Case Report and Literature Review.

Authors:  Fahmi Yousef Khan; Mohammed AbuKamar; Deshmukh Anand
Journal:  Oman Med J       Date:  2017-03

5.  A Lethal Case of Pseudomonas putida Bacteremia Due to Soft Tissue Infection.

Authors:  Benjamin S Thomas; Koh Okamoto; Matthew J Bankowski; Todd B Seto
Journal:  Infect Dis Clin Pract (Baltim Md)       Date:  2013-05

6.  Nosocomial Pseudomonas putida Bacteremia: High Rates of Carbapenem Resistance and Mortality.

Authors:  Seong Eun Kim; Seong-Hwan Park; Hyun Bum Park; Kyung-Hwa Park; Su-Hyun Kim; Sook-In Jung; Jong-Hee Shin; Hee-Chang Jang; Seung Ji Kang
Journal:  Chonnam Med J       Date:  2012-08-24

7.  Diabetic Foot Gangrene Patient with Multi-drug Resistant Pseudomonas Putida Infection in Karawaci District, Indonesia.

Authors:  Nata Pratama Hardjo Lugito; Cucu Nawangsih; Jevany Claudia Moksidy; Andree Kurniawan; Margaret Merlyn Tjiang
Journal:  J Glob Infect Dis       Date:  2015 Jan-Mar

8.  Alterations in the colonic microbiota in response to osmotic diarrhea.

Authors:  Gregor Gorkiewicz; Gerhard G Thallinger; Slave Trajanoski; Stefan Lackner; Gernot Stocker; Thomas Hinterleitner; Christian Gülly; Christoph Högenauer
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

9.  Bacteria-induced nasal necrosis with negative cultures.

Authors:  Ashwini Milind Tilak; Jessica Bishop; Harishanker Jeyarajan; Jessica Grayson
Journal:  BMJ Case Rep       Date:  2020-08-18

10.  Neonatal Pseudomonas putida infection presenting as staphylococcal scalded skin syndrome.

Authors:  S Ladhani; Z A Bhutta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.